Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joy Derwenskus"'
Autor:
Topaz investigators, Colin Mitchell, Elisabeth Gulowsen Celius, Stephen G Vincent, Renata Simm, Luke Chung, George J. Hutton, Anat Achiron, Camms , Care-Ms I, Care-Ms Ii, Camms, Jean-Raphael Schneider, David Rog, Marie Moore, Christina D. Chambers, Joy Derwenskus, Nadia Daizadeh, Pamela A. McCombe, Kerstin Hellwig, Virginia Devonshire, Lívia Sousa, Jiwon Oh, D Alastair S Compston
Background Relapsing-remitting multiple sclerosis (RRMS) is frequently diagnosed in women of reproductive age. Because the use of disease-modifying therapies (DMTs) early in the disease course is increasing, it is important to evaluate the safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::116fc430be851f4ebfdc13da3932c7a6
http://hdl.handle.net/10852/85205
http://hdl.handle.net/10852/85205
Autor:
Joy Derwenskus
Publikováno v:
Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine. 78:161-175
The treatment era for multiple sclerosis began in 1993 with the approval of the first disease-modifying therapy. This changed the management of multiple sclerosis from treating acute exacerbations to focusing on preventive therapeutic options that le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb613d1aa9692ae8a61eb345a7ba82d8
https://doi.org/10.1002/msj.20239
https://doi.org/10.1002/msj.20239
Autor:
Joy, Derwenskus, Fred D, Lublin
Publikováno v:
Handbook of clinical neurology. 122
The modern treatment era for multiple sclerosis (MS) began in 1993 with the approval of the first disease-modifying agent. Since then the field has greatly expanded, with 10 therapies currently approved to treat MS. These treatments are effective to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0ece81a189f96a52c17a4518bdb7bc9
https://pubmed.ncbi.nlm.nih.gov/24507535
https://pubmed.ncbi.nlm.nih.gov/24507535
Autor:
Fred D. Lublin, Joy Derwenskus
The modern treatment era for multiple sclerosis (MS) began in 1993 with the approval of the first disease-modifying agent. Since then the field has greatly expanded, with 10 therapies currently approved to treat MS. These treatments are effective to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d594bf293d55a9bc6ba460e241f4b97
https://doi.org/10.1016/b978-0-444-52001-2.00024-8
https://doi.org/10.1016/b978-0-444-52001-2.00024-8
Autor:
Nancy Adams, Deborah Downey, John S. Stahl, Joy Derwenskus, Alessandro Serra, Janet C. Rucker, R. John Leigh
Publikováno v:
Annals of the New York Academy of Sciences. 1039:521-523
We conducted a two-year follow-up study of 40 patients with MS in whom we had reported that abnormal eye movements (AEM) were associated with greater general disability. AEM patients (17/40) remained significantly (p < .001) more disabled (median EDS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d777686801bb1509a05dd01fefb1b8f
https://doi.org/10.1196/annals.1325.058
https://doi.org/10.1196/annals.1325.058
Autor:
R. John Leigh, Deborah Downey, Joy Derwenskus, Roongroj Bhidayasiri, Nancy Adams, Robert L. Ruff, John S. Stahl
Publikováno v:
Annals of the New York Academy of Sciences. 956:438-440
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcb044e56ea756971c511329c5fb21f7
https://doi.org/10.1111/j.1749-6632.2002.tb02849.x
https://doi.org/10.1111/j.1749-6632.2002.tb02849.x
Autor:
Joy, Derwenskus
Publikováno v:
The Mount Sinai journal of medicine, New York. 78(2)
The treatment era for multiple sclerosis began in 1993 with the approval of the first disease-modifying therapy. This changed the management of multiple sclerosis from treating acute exacerbations to focusing on preventive therapeutic options that le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::96776b9b44ec1e328b1f027b4dbe8676
https://pubmed.ncbi.nlm.nih.gov/21425262
https://pubmed.ncbi.nlm.nih.gov/21425262
Autor:
Joy, Derwenskus, Fred D, Lublin
Publikováno v:
Advances in neurology. 98
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eaa04df59e23c0c8c8ec3e606065a5be
https://pubmed.ncbi.nlm.nih.gov/16400838
https://pubmed.ncbi.nlm.nih.gov/16400838
Publikováno v:
Neurology. 63(7)
A 45-year-old African-American woman with previous history of diabetes, hypertension, and hypercholesterolemia presented with speech and word-finding difficulties. She complained of right-sided facial droop and upper limb weakness and numbness. Neuro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a380e01c73a5bc7e7775b1ff315dfc7e
https://pubmed.ncbi.nlm.nih.gov/15477553
https://pubmed.ncbi.nlm.nih.gov/15477553
Autor:
Joy Derwenskus, Osama O. Zaidat
Publikováno v:
Critical Care Neurology and Neurosurgery ISBN: 9781617373503
Acute spinal cord injury (SCI), whether traumatic or nontraumatic in etiology, has a tremendous cost not only for patients and families, but also for society as a whole. The incidence of SCI in the United States is estimated to be 30–40 cases per 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cef4d9012223eaa6b2aad0feebac154f
https://doi.org/10.1007/978-1-59259-660-7_23
https://doi.org/10.1007/978-1-59259-660-7_23